Sonnet BioTherapeutics Holdings, Inc. disclosed in an 8-K filing with the SEC on November 6, 2024, that it has successfully completed an underwritten public offering aimed at raising $5.0 million in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback